Sho Tsukamoto

Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling

Sho Tsukamoto, Takato Mizuta, Mai Fujimoto et al. · Scientific Reports · 2014 · 117 citations · Full text

Effects of FKBP12 and type II BMP receptors on signal transduction by ALK2 activating mutations associated with genetic disorders

Aiko Machiya, Sho Tsukamoto, Satoshi Ohte et al. · Bone · 2018 · 32 citations · Full text

Sclerostin, Genetics, Disease Gene Identification +16

Mutant Activin-Like Kinase 2 in Fibrodysplasia Ossificans Progressiva are Activated via T203 by BMP Type II Receptors

Mai Fujimoto, Satoshi Ohte, Kenji Osawa et al. · Molecular Endocrinology · 2014 · 26 citations · Full text

Mechanobiology, Fop Patients, Sclerostin +15

Expression of TLE3 by bone marrow stromal cells is regulated by canonical Wnt signaling

Shoichiro Kokabu, Tsuyoshi Sato, Satoshi Ohte et al. · FEBS Letters · 2014 · 22 citations

Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes

Masashi Shin, Satoshi Ohte, Toru Fukuda et al. · Journal of Bone and Mineral Metabolism · 2012 · 22 citations

Bioinformatics, Bmp-responsive Elements, Sclerostin +11